Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NHGRI

A Method of Detecting Molecules in Proximity to a Target Molecule in a Sample

  • Read more about A Method of Detecting Molecules in Proximity to a Target Molecule in a Sample
US Application 62/211,160
Filed on 2015-08-28

Tagged Form Of Mut Enzyme, Genetic Constructs Incorporating It, And Its Use In Gene Therapy

  • Read more about Tagged Form Of Mut Enzyme, Genetic Constructs Incorporating It, And Its Use In Gene Therapy
US Application 62/152,520
Filed on 2015-04-24

Sialylation-increasing Therapies For Diseases Associated With Oxidative Stress

  • Read more about Sialylation-increasing Therapies For Diseases Associated With Oxidative Stress
US Application 62/120,742
Filed on 2015-02-25

VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER

  • Read more about VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER
US Application 62/144,702
Filed on 2015-04-08

METHODS OF TREATING PXE WITH TNAP INHIBITORS

  • Read more about METHODS OF TREATING PXE WITH TNAP INHIBITORS
US Application 62/058,505
Filed on 2014-10-01

Compounds and Method for Treating PARP1-Deficient Cancers

  • Read more about Compounds and Method for Treating PARP1-Deficient Cancers
US Application 61/988,502
Filed on 2014-05-05

Compounds and Method for Treating PARP1-Deficient Cancers

  • Read more about Compounds and Method for Treating PARP1-Deficient Cancers
US Application 61/930,291
Filed on 2014-01-22

METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY MLL FUSION PROTEINS

  • Read more about METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY MLL FUSION PROTEINS
US Application 61/736,459
Filed on 2012-12-12

Compositions and Methods for Predicting Age of Onset of A Lysosomal Storage Disease or a Disease Associated with a Lysosomal Defect

  • Read more about Compositions and Methods for Predicting Age of Onset of A Lysosomal Storage Disease or a Disease Associated with a Lysosomal Defect
US Application 61/781,807
Filed on 2013-03-14

Biomarker For Hyposialylation Disorders

  • Read more about Biomarker For Hyposialylation Disorders
US Application 61/785,094
Filed on 2013-03-14

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • …
  • Next page ››
  • Last page Last »
Subscribe to NHGRI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health